Mixing study (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Mixing study" in English language version.

refsWebsite

Global rank English rank

13nih.gov

4^th place

12doi.org

2^nd place

6books.google.com

3^rd place

2semanticscholar.org

11^th place

8^th place

2worldcat.org

5^th place

1ugent.be

3,695^th place

3,560^th place

1clinlabnavigator.com

low place

1kingbiomed.com

low place

books.google.com

Lanzkowsky P (2005-06-06). Manual of Pediatric Hematology and Oncology. Elsevier. ISBN 978-0-08-049731-0.
Hoffman R, Benz EJ, Silberstein LE, Heslop H, Anastasi J, Weitz J (2013-01-01). Hematology: Basic Principles and Practice. Elsevier Health Sciences. ISBN 978-1-4377-2928-3.
Gupta P, Menon PS, Ramji S, Lodha R (2015-08-31). PG Textbook of Pediatrics: Volume 2: Infections and Systemic Disorders. JP Medical. ISBN 978-93-5152-955-2.
Med Lab Tech Vol 1, 2/e. Tata McGraw-Hill Education. 2010. ISBN 978-0-07-007659-4.
Bain BJ, Bates I, Laffan MA (2016-08-11). Dacie and Lewis Practical Haematology E-Book. Elsevier Health Sciences. ISBN 978-0-7020-6925-3.
McPherson RA, Pincus MR (2011-09-06). Henry's Clinical Diagnosis and Management by Laboratory Methods E-Book. Elsevier Health Sciences. ISBN 978-1-4557-2684-4.

clinlabnavigator.com

"Heparin Neutralization". www.clinlabnavigator.com. Retrieved 2018-05-13.

doi.org

Devreese KM (2007). "Interpretation of normal plasma mixing studies in the laboratory diagnosis of lupus anticoagulants". Thrombosis Research. 119 (3): 369–76. doi:10.1016/j.thromres.2006.03.012. PMID 16704874.
Mackie I, Casini A, Pieters M, Pruthi R, Reilly-Stitt C, Suzuki A (February 2024). "International council for standardisation in haematology recommendations on fibrinogen assays, thrombin clotting time and related tests in the investigation of bleeding disorders". Int J Lab Hematol. 46 (1): 20–32. doi:10.1111/ijlh.14201. PMID 37984807.
Franchini M, Castaman G, Coppola A, Santoro C, Zanon E, Di Minno G, Morfini M, Santagostino E, Rocino A (July 2015). "Acquired inhibitors of clotting factors: AICE recommendations for diagnosis and management". Blood Transfusion. 13 (3): 498–513. doi:10.2450/2015.0141-15. PMC 4614303. PMID 26192778.
Lusher JM (2000). "Inhibitor antibodies to factor VIII and factor IX: management". Seminars in Thrombosis and Hemostasis. 26 (2): 179–88. doi:10.1055/s-2000-9821. PMID 10919411. S2CID 43124794.
Shima M (August 2024). "Current status and future prospects of activated recombinant coagulation factor VIIa, NovoSeven®, in the treatment of haemophilia and rare bleeding disorders". Ann Hematol. 103 (8): 2647–58. doi:10.1007/s00277-023-05287-2. PMC 11283401. PMID 37391649.
Rungjirajittranon T, Suwanawiboon B, Nakkinkun Y, Leelakanok N, Kaokunakorn T, Chinthammitr Y, Owattanapanich W, Ruchutrakool T (June 2024). "First-line immunosuppressive therapies for acquired hemophilia A: A 25-year cohort experience and network meta-analysis". Thromb Res. 241: 109067. doi:10.1016/j.thromres.2024.109067. PMID 38970991.
Favaloro EJ (January 2020). "Coagulation mixing studies: Utility, algorithmic strategies and limitations for lupus anticoagulant testing or follow up of abnormal coagulation tests". Am J Hematol. 95 (1): 117–128. doi:10.1002/ajh.25669. PMID 31674066.
Baig MA, Swamy KB (2021). "Comparative analysis of chromogenic vs clot.based one stage APTT assay for determination of factor VIII level". Indian J Pathol Microbiol. 64 (1): 123–7. doi:10.4103/IJPM.IJPM_900_19. PMID 33433421.
Rosner, Esther; Pauzner, Rachel; Lusky, Ayala; Modan, Michaela; Many, Amira (1987). "Detection and Quantitative Evaluation of Lupus Circulating Anticoagulant Activity". Thrombosis and Haemostasis. 57 (2): 144–7. doi:10.1055/s-0038-1651083. ISSN 0340-6245. PMID 3110995. S2CID 37633238.
Chang, Sheng-hsiung; Tillema, Veronica; Scherr, Doris (January 2002). "A "Percent Correction" Formula for Evaluation of Mixing Studies". American Journal of Clinical Pathology. 117 (1): 62–73. doi:10.1309/rrek-8l6m-d2kc-hwlh. ISSN 0002-9173. PMID 11789732.
Chen J, Phillips B, Chandler WL (January 2016). "Evaluation of prothrombin time and activated partial thromboplastin time mixing studies using an estimated factor correction method". Blood Coagul Fibrinolysis. 27 (1): 90–6. doi:10.1097/MBC.0000000000000375. PMID 26397883.

dx.doi.org

Rosner, Esther; Pauzner, Rachel; Lusky, Ayala; Modan, Michaela; Many, Amira (1987). "Detection and Quantitative Evaluation of Lupus Circulating Anticoagulant Activity". Thrombosis and Haemostasis. 57 (2): 144–7. doi:10.1055/s-0038-1651083. ISSN 0340-6245. PMID 3110995. S2CID 37633238.

kingbiomed.com

"Making Sense of Mixing Studies". George King Bio-Medical, Inc. 2016-01-07. Retrieved 2018-05-13.

nih.gov

pubmed.ncbi.nlm.nih.gov

Devreese KM (2007). "Interpretation of normal plasma mixing studies in the laboratory diagnosis of lupus anticoagulants". Thrombosis Research. 119 (3): 369–76. doi:10.1016/j.thromres.2006.03.012. PMID 16704874.
Mackie I, Casini A, Pieters M, Pruthi R, Reilly-Stitt C, Suzuki A (February 2024). "International council for standardisation in haematology recommendations on fibrinogen assays, thrombin clotting time and related tests in the investigation of bleeding disorders". Int J Lab Hematol. 46 (1): 20–32. doi:10.1111/ijlh.14201. PMID 37984807.
Franchini M, Castaman G, Coppola A, Santoro C, Zanon E, Di Minno G, Morfini M, Santagostino E, Rocino A (July 2015). "Acquired inhibitors of clotting factors: AICE recommendations for diagnosis and management". Blood Transfusion. 13 (3): 498–513. doi:10.2450/2015.0141-15. PMC 4614303. PMID 26192778.
Lusher JM (2000). "Inhibitor antibodies to factor VIII and factor IX: management". Seminars in Thrombosis and Hemostasis. 26 (2): 179–88. doi:10.1055/s-2000-9821. PMID 10919411. S2CID 43124794.
Shima M (August 2024). "Current status and future prospects of activated recombinant coagulation factor VIIa, NovoSeven®, in the treatment of haemophilia and rare bleeding disorders". Ann Hematol. 103 (8): 2647–58. doi:10.1007/s00277-023-05287-2. PMC 11283401. PMID 37391649.
Rungjirajittranon T, Suwanawiboon B, Nakkinkun Y, Leelakanok N, Kaokunakorn T, Chinthammitr Y, Owattanapanich W, Ruchutrakool T (June 2024). "First-line immunosuppressive therapies for acquired hemophilia A: A 25-year cohort experience and network meta-analysis". Thromb Res. 241: 109067. doi:10.1016/j.thromres.2024.109067. PMID 38970991.
Favaloro EJ (January 2020). "Coagulation mixing studies: Utility, algorithmic strategies and limitations for lupus anticoagulant testing or follow up of abnormal coagulation tests". Am J Hematol. 95 (1): 117–128. doi:10.1002/ajh.25669. PMID 31674066.
Baig MA, Swamy KB (2021). "Comparative analysis of chromogenic vs clot.based one stage APTT assay for determination of factor VIII level". Indian J Pathol Microbiol. 64 (1): 123–7. doi:10.4103/IJPM.IJPM_900_19. PMID 33433421.
Rosner, Esther; Pauzner, Rachel; Lusky, Ayala; Modan, Michaela; Many, Amira (1987). "Detection and Quantitative Evaluation of Lupus Circulating Anticoagulant Activity". Thrombosis and Haemostasis. 57 (2): 144–7. doi:10.1055/s-0038-1651083. ISSN 0340-6245. PMID 3110995. S2CID 37633238.
Chang, Sheng-hsiung; Tillema, Veronica; Scherr, Doris (January 2002). "A "Percent Correction" Formula for Evaluation of Mixing Studies". American Journal of Clinical Pathology. 117 (1): 62–73. doi:10.1309/rrek-8l6m-d2kc-hwlh. ISSN 0002-9173. PMID 11789732.
Chen J, Phillips B, Chandler WL (January 2016). "Evaluation of prothrombin time and activated partial thromboplastin time mixing studies using an estimated factor correction method". Blood Coagul Fibrinolysis. 27 (1): 90–6. doi:10.1097/MBC.0000000000000375. PMID 26397883.

ncbi.nlm.nih.gov

Franchini M, Castaman G, Coppola A, Santoro C, Zanon E, Di Minno G, Morfini M, Santagostino E, Rocino A (July 2015). "Acquired inhibitors of clotting factors: AICE recommendations for diagnosis and management". Blood Transfusion. 13 (3): 498–513. doi:10.2450/2015.0141-15. PMC 4614303. PMID 26192778.
Shima M (August 2024). "Current status and future prospects of activated recombinant coagulation factor VIIa, NovoSeven®, in the treatment of haemophilia and rare bleeding disorders". Ann Hematol. 103 (8): 2647–58. doi:10.1007/s00277-023-05287-2. PMC 11283401. PMID 37391649.

semanticscholar.org

api.semanticscholar.org

Lusher JM (2000). "Inhibitor antibodies to factor VIII and factor IX: management". Seminars in Thrombosis and Hemostasis. 26 (2): 179–88. doi:10.1055/s-2000-9821. PMID 10919411. S2CID 43124794.
Rosner, Esther; Pauzner, Rachel; Lusky, Ayala; Modan, Michaela; Many, Amira (1987). "Detection and Quantitative Evaluation of Lupus Circulating Anticoagulant Activity". Thrombosis and Haemostasis. 57 (2): 144–7. doi:10.1055/s-0038-1651083. ISSN 0340-6245. PMID 3110995. S2CID 37633238.

ugent.be

biblio.ugent.be

Devreese KM (2007). "Interpretation of normal plasma mixing studies in the laboratory diagnosis of lupus anticoagulants". Thrombosis Research. 119 (3): 369–76. doi:10.1016/j.thromres.2006.03.012. PMID 16704874.

worldcat.org

search.worldcat.org

Rosner, Esther; Pauzner, Rachel; Lusky, Ayala; Modan, Michaela; Many, Amira (1987). "Detection and Quantitative Evaluation of Lupus Circulating Anticoagulant Activity". Thrombosis and Haemostasis. 57 (2): 144–7. doi:10.1055/s-0038-1651083. ISSN 0340-6245. PMID 3110995. S2CID 37633238.
Chang, Sheng-hsiung; Tillema, Veronica; Scherr, Doris (January 2002). "A "Percent Correction" Formula for Evaluation of Mixing Studies". American Journal of Clinical Pathology. 117 (1): 62–73. doi:10.1309/rrek-8l6m-d2kc-hwlh. ISSN 0002-9173. PMID 11789732.